{"doi":"10.1111/ctr.70009","title":"CAV Trajectories Among Patients With No or Mild CAV at 10 Years Posttransplant","abstract":"Cardiac allograft vasculopathy (CAV) is a major cause of morbidity and mortality following heart transplantation (HT). Prior studies identified distinct CAV trajectories in the early post-HT period with unique predictors, but the evolution of CAV in later periods is not well-described. This study assessed the prevalence of late CAV progression and associated risk factors in HT recipients with ISHLT CAV 0/1 at 10 years post-HT. Consecutive adult patients who underwent HT from January 2000 to December 2008 were evaluated and grouped by CAV trajectories into progressors (developed ISHLT CAV 2/3) or nonprogressors (remained ISHLT CAV 0/1). A total of 130 patients were included with a median age at angiography of 61.7 years and a median follow-up time of 4.8 years. 8.5% progressed to CAV 2/3, while the remaining 91.5% were nonprogressors. Progression was not associated with death or retransplantation (27.3% [progressor] vs. 21.0% [nonprogressor], p = 0.70). These data may inform shared decision-making about late CAV screening.","journal":"Clinical Transplantation","year":2024,"id":481910,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.966,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1259118,"name":"Nikil Prasad","orcid":null,"position":1,"is_corresponding":false},{"id":1322265,"name":"Devin Skoll","orcid":null,"position":2,"is_corresponding":false},{"id":1322266,"name":"Sambhavi Sneha Kumar","orcid":null,"position":3,"is_corresponding":false},{"id":1254392,"name":"Justin Fried","orcid":null,"position":4,"is_corresponding":false},{"id":271777,"name":"Veli K. Topkara","orcid":"0000-0002-2236-2008","position":5,"is_corresponding":false},{"id":281839,"name":"J. Raikhelkar","orcid":"0000-0002-8561-7899","position":6,"is_corresponding":false},{"id":260663,"name":"Ersilia M. DeFilippis","orcid":"0000-0002-0493-1326","position":7,"is_corresponding":false},{"id":494070,"name":"F. Latif","orcid":"0000-0002-4127-656X","position":8,"is_corresponding":false},{"id":271769,"name":"M. Yuzefpolskaya","orcid":"0000-0003-4729-8943","position":9,"is_corresponding":false},{"id":271781,"name":"P.C. Colombo","orcid":"0000-0003-4977-3285","position":10,"is_corresponding":false},{"id":104009,"name":"Nir Uriel","orcid":"0000-0003-2301-3587","position":11,"is_corresponding":false},{"id":199059,"name":"Koji Takeda","orcid":null,"position":12,"is_corresponding":false},{"id":1253810,"name":"G. Sayer","orcid":"0000-0001-9508-5657","position":13,"is_corresponding":false},{"id":281842,"name":"Kevin J. Clerkin","orcid":"0000-0001-8351-9219","position":14,"is_corresponding":false},{"id":1096147,"name":"Erin Harris","orcid":"0000-0002-3367-5720","position":0,"is_corresponding":true}],"reference_count":4,"raw_metadata":null,"created_at":"2026-07-19T02:07:10.067421Z","pmid":"39436145","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}